genomics « Science and Enterprise

Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds

By Alan, on June 7th, 2023%

A developer of nanoscale lipid particles for delivering genomic therapies to specific cells and tissue, spun-off from academic labs, is raising $25 million in seed funds. . . . → Read More: Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds

Primate Genome A.I. Model IDs Human Disease Variants

By Alan, on June 2nd, 2023%

A genomic systems company created an artificial intelligence algorithm from primate genomic data that identifies possible disease-causing mutations in humans. . . . → Read More: Primate Genome A.I. Model IDs Human Disease Variants

Crispr Therapy Shown to Reduce Harmful Gut Microbes

By Alan, on May 31st, 2023%

A clinical trial shows an oral therapy with engineered viruses delivers precise gene-edited payloads to reduce E. coli communities in the gut with no serious adverse effects. . . . → Read More: Crispr Therapy Shown to Reduce Harmful Gut Microbes

Precision T-Cell Solid Tumor Therapy Trial Underway

By Alan, on May 30th, 2023%

A clinical trial has begun testing a treatment for solid tumor cancers using engineered T-cells with proteins to attack specific tumor cells, but also avoid healthy cells. . . . → Read More: Precision T-Cell Solid Tumor Therapy Trial Underway

AI-Designed Cancer Vaccine Shown to Act Against Melanoma

By Alan, on May 26th, 2023%

Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors. . . . → Read More: AI-Designed Cancer Vaccine Shown to Act Against Melanoma

Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

By Alan, on May 24th, 2023%

A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders. . . . → Read More: Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

$60M Challenge Seeks Biomarkers, Models to Counter Aging Stress

By Alan, on May 19th, 2023%

A new challenge competition seeks biomarkers, models, and clinical tests of the factors behind responses to stress conditions in human aging that can stave off frailty or death. . . . → Read More: $60M Challenge Seeks Biomarkers, Models to Counter Aging Stress

Biotech, Janssen Partner on Ultrasound for Gene Therapy

By Alan, on May 16th, 2023%

A developer of ultrasound bubbles to assist gene therapies is studying use of the technology with Janssen Pharmaceuticals for delivering DNA and RNA treatments. . . . → Read More: Biotech, Janssen Partner on Ultrasound for Gene Therapy

Rare Disease Search Adds Large Language Model A.I.

By Alan, on May 15th, 2023%

A company offering a search engine to help diagnose rare diseases is integrating generative models from Open AI into its artificial intelligence algorithms. . . . → Read More: Rare Disease Search Adds Large Language Model A.I.

Computational Drug Discovery Company Acquires A.I. Businesses

By Alan, on May 8th, 2023%

Two companies using artificial intelligence to advance biotechnology and design new therapies are merging with a computational-engineering drug discovery enterprise. . . . → Read More: Computational Drug Discovery Company Acquires A.I. Businesses

Subscribe for email alerts

Donate to Science & Enterprise

Like us on Facebook

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Specials

Guest Posts

Please share Science & Enterprise